High incidence of thrombosis and venous thromboembolism was reported in patients with COVID-19. In this study, we focused on analysis of thrombophilic mutations performed without a standard DNA extraction step. In one hundred of COVID-19 positive outpatients, real-time PCR for Leiden mutation in the FV gene and G20210A mutation in the FII gene was carried out from DNA extracts and modified whole blood samples, and their cycle threshold (Ct) values were evaluated. In the extracts, healthy homozygotes (wt/wt), heterozygotes (M/wt), and homozygous carriers of Leiden mutation (M/M) provided median Ct values of 18.5, 19.4/22.0, and 20.9. In the whole blood, Ct values were 25.3 (wt/wt), 24.8/27.2 (M/wt), and 26.9 (M/M). Median Ct values for G20210A in the extracts were 19.6 for homozygotes (wt/wt), and 19.7/20.4 for heterozygous carriers. The whole blood samples provided Ct values of 23.9 in healthy homozygotes and 26.3/27.2 in heterozygotes for G20210A mutation. No homozygous subjects for G20210A and no double heterozygotes (for Leiden and G20210A mutations) were found. Despite significant differences in the Ct values, genotyping showed complete result concordance of the DNA extracts and the whole blood samples. The integrity and amplificability of DNA molecules in the whole blood samples during 28 days of deep freezing, interrupted by four cycles of thawing, did not significantly change. In conclusion, we demonstrated a new protocol for the detection of the thrombophilic mutations via real time PCR on the modified whole blood of COVID-19 positive patients. The blood modification was reliable, easy, cheap, and saving costs and turnaround time of the whole laboratory process.

Institute of Clinical Biochemistry and Diagnostics Charles University Hospital Hradec Králové Czech Republic

Zobrazit více v PubMed

Johns Hopkins Coronavirus Resource Center. website: https://coronavirus.jhu.edu/map.html.

Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thromb Res. 2020;194:101–115. doi: 10.1016/j.thromres.2020.06.029. PubMed DOI PMC

Stefely JA, Christensen BB, Gogakos T, Cone Sullivan JK, Montgomery GG, Barranco JP, Van Cott EM. Marked factor V activity elevation in severe COVID-19 is associated with venous thromboembolism. Am J Hematol. 2020;95:1522–1530. doi: 10.1002/ajh.25979. PubMed DOI PMC

Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) Blood. 1995;85:1504–1508. doi: 10.1182/blood.V85.6.1504.bloodjournal8561504. PubMed DOI

Poort SR, Rosendaal FR, Reitsma PH. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698–3703. doi: 10.1182/blood.V88.10.3698.bloodjournal88103698. PubMed DOI

Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 1993;342:1503–1506. doi: 10.1016/S0140-6736(05)80081-9. PubMed DOI

Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, Psaltopoulou T, Gerotziafas G, Dimopoulos MA. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95:834–847. doi: 10.1002/ajh.25829. PubMed DOI PMC

Scobie GA, Ho ST, Dolan G, Kalsheker NA. Development of a rapid DNA screening procedure for the Factor V Leiden mutation. Clin Mol Pathol. 1996;49:M361–M363. doi: 10.1136/mp.49.6.m361. PubMed DOI PMC

Sinclair GD, Low S, Poon MC. A hemi-nested, allele specific, whole blood PCR assay for the detection of the factor V Leiden mutation. Thromb Haemost. 1997;77:1154–1155. doi: 10.1055/s-0038-1656129. PubMed DOI

Rees DC, Cox M, Clegg JB. Detection of the factor V Leiden mutation using whole blood PCR. Thromb Haemost. 1996;75:520–521. doi: 10.1055/s-0038-1650309. PubMed DOI

Corral J, Iniesta JA, González-Conejero R, Vicente V. Detection of factor V Leiden from a drop of blood by PCR-SSCP. Thromb Haemost. 1996;76:735–737. doi: 10.1055/s-0038-1650652. PubMed DOI

Castley A, Higgins M, Ivey J, Mamotte C, Sayer DC, Christiansen FT. Clinical applications of whole-blood PCR with real-time instrumentation. Clin Chem. 2005;51:2025–2030. doi: 10.1373/clinchem.2005.055327. PubMed DOI

Geiger K, Leiherer A, Brandtner EM, Fraunberger P, Drexel H, Muendlein A. Direct blood PCR: TaqMan-probe based detection of the venous thromboembolism associated mutations factor V Leiden and prothrombin c.20210G>A without DNA extraction. Clin Chim Acta. 2019;488:221–225. doi: 10.1016/j.cca.2018.11.016. PubMed DOI

Luca Tiscia G, Colaizzo D, Vergura P, Favuzzi G, Chinni E, Vandermeulen C, Detemmerman L, Grandone E. Loop-mediated isothermal amplification (LAMP)-based method for detecting factor V Leiden and factor II G20210A common variants. J Thromb Thrombolysis. 2020;50:908–912. doi: 10.1007/s11239-020-02183-8. PubMed DOI

Novysedlak R, Vachtenheim J, Jr, Stříž I, Viklický O, Lischke R, Strizova Z. SARS-CoV-2 viral load assessment in lung transplantation. Physiol Res. 2021;70(Suppl 2):S253–S258. doi: 10.33549/physiolres.934760. PubMed DOI PMC

Burckhardt J. Amplification of DNA from whole blood. PCR Methods Appl. 1994;3:239–243. doi: 10.1101/gr.3.4.239. PubMed DOI

Geiger K, Zach C, Leiherer A, Fraunberger P, Drexel H, Muendlein A. Real-time PCR based HLA-B*27 screening directly in whole blood. HLA. 2020;95:189–195. doi: 10.1111/tan.13767. PubMed DOI

Muendlein A, Leiherer A, Zach C, Brandtner EM, Fraunberger P, Drexel H, Geiger K. Real-time PCR based detection of the lactase non-persistence associated genetic variant LCT-13910C>T directly from whole blood. Mol Biol Rep. 2019;46:2379–2385. doi: 10.1007/s11033-019-04696-9. PubMed DOI

Desjonquères A, Ménard A, Detemmerman L, Ternisien C, Fouassier M, Gillet B, Béné MC, Le Bris Y. Confirmed validation of an innovative PCR-assay without DNA extraction for multiplex diagnosis of factor V Leiden and prothrombin gene variants. Thromb Res. 2019;183:143–145. doi: 10.1016/j.thromres.2019.09.031. PubMed DOI

Soejima M, Egashira K, Kawano H, Kawaguchi A, Sagawa K, Koda Y. Rapid detection of haptoglobin gene deletion in alkaline-denatured blood by loop-mediated isothermal amplification reaction. J Mol Diagn. 2011;13:334–339. doi: 10.1016/j.jmoldx.2011.01.005. PubMed DOI PMC

Kvasnička T, Hájková J, Bobčíková P, Cverhová V, Malíková I, Ulrych J, Bříza J, Dušková D, Poletínová S, Kieferová V, Kvasnička J. The frequencies of six important thrombophilic mutations in a population of the Czech Republic. Physiol Res. 2014;63:245–253. doi: 10.33549/physiolres.932618. PubMed DOI

Beránek M, Drastíková M, Dulíček P, Palička V. Preparing compound heterozygous reference material using gene synthesis technology: a model of thrombophilic mutations. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158:539–543. doi: 10.5507/bp.2014.041. PubMed DOI

García ME, Blanco JL, Caballero J, Gargallo-Viola D. Anticoagulants interfere with PCR used to diagnose invasive aspergillosis. J Clin Microbiol. 2002;40:1567–1568. doi: 10.1128/JCM.40.4.1567-1568.2002. PubMed DOI PMC

Taylor AC. Titration of heparinase for removal of the PCR-inhibitory effect of heparin in DNA samples. Mol Ecol. 1997;6:383–385. doi: 10.1046/j.1365-294x.1997.00191.x. PubMed DOI

Jung R, Lübcke C, Wagener C, Neumaier M. Reversal of RT-PCR inhibition observed in heparinized clinical specimens. Biotechniques. 1997;23:24, 26, 28. doi: 10.2144/97231bm03. PubMed DOI

Djordjevic V, Stankovic M, Nikolic A, Antonijevic N, Rakicevic LJ, Divac A, Radojkovic M. PCR amplification on whole blood samples treated with different commonly used anticoagulants. Pediatr Hematol Oncol. 2006;23:517–521. doi: 10.1080/08880010600751900. PubMed DOI

Yedidag EN, Koffron AJ, Mueller KH, Kaplan B, Kaufman DB, Fryer JP, Stuart FP, Abecassis M. Acyclovir triphosphate inhibits the diagnostic polymerase chain reaction for cytomegalovirus. Transplantation. 1996;62:238–242. doi: 10.1097/00007890-199607270-00015. PubMed DOI

Hotta K, Zhu CB, Phomsuwansiri P, Ishikawa J, Mizuno S, Hatsu M, Imai S. PCR inhibition assay for DNA-targeted antibiotics. J Antibiot (Tokyo) 1995;48:1267–1272. doi: 10.7164/antibiotics.48.1267. PubMed DOI